AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

BESLER GIDA VE KİMYA SANAYİ VE TİCARET A.Ş.

Quarterly Report Nov 10, 2025

10641_rns_2025-11-10_5ff57d8c-01e1-485a-b424-a4a08c41fc13.pdf

Quarterly Report

Open in Viewer

Opens in native device viewer

BESLER GIDA VE KİMYA SANAYİ VE TİCARET A.Ş. AND ITS SUBSIDIARIES

CONVENIENCE TRANSLATION INTO ENGLISH OF CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 1 JANUARY - 30 SEPTEMBER 2025 (ORIGINALLY ISSUED IN TURKISH)

BESLER GIDA VE KİMYA SANAYİ VE TİCARET A.Ş. AND ITS SUBSIDIARIES

CONTENTS PAGE
CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL
POSITION
1-3
CONDENSED
CONSOLIDATED STATEMENT OF PROFIT OR LOSS AND OTHER
COMPREHENSIVE INCOME
4
CONDENSED
CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
5
CONDENSED
CONSOLIDATED STATEMENT OF CASH FLOWS
6-7
NOTES TO THE CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS
8-41
NOTE 1
GROUP'S ORGANIZATION AND NATURE OF OPERATIONS
8-9
NOTE 2
BASIS OF PRESENTATION OF CONSOLIDATED FINANCIAL STATEMENTS
9-14
NOTE 3
SEGMENT REPORTING
15
NOTE 4
RELATED PARTY DISCLOSURES
15-19
NOTE 5
TRADE RECEIVABLES AND PAYABLES
19-20
NOTE 6
OTHER RECEIVABLES AND PAYABLES
21
NOTE 7
INVENTORIES
21
NOTE 8
PREPAID EXPENSES AND DEFERRED REVENUE
22
NOTE 9
INVESTMENT PROPERTIES
22-23
NOTE 10 PROPERTY, PLANT AND EQUIPMENT 24-25
NOTE 11 INTANGIBLE ASSETS 26-27
NOTE 12 GOVERMENT GRANTS AND INCENTIVES 27
NOTE 13 PROVISIONS, CONTINGENT ASSETS AND LIABILITIES 28
NOTE 14 COMMITMENTS AND CONTINGENCIES 29
NOTE 15 OTHER ASSETS AND LIABILITIES 30
NOTE 16 CAPITAL, RESERVES AND OTHER EQUITY ITEMS 30-31
NOTE 17 REVENUE AND COST OF SALES 31
NOTE 18 GENERAL ADMINISTRATIVE EXPENSES, MARKETING EXPENSES, RESEARCH AND
DEVELOPMENT EXPENSES 31-32
NOTE 19 INCOME AND EXPENSES FROM INVESTMENT ACTIVITIES 32
NOTE 20 FINANCIAL INCOME AND EXPENSES 33
NOTE 21 MONETARY GAİN LOSS 34
NOTE 22 INCOME TAXES (INCLUDING DEFERRED TAX ASSETS AND LIABILITIES) 35-36
NOTE 23 EARNING PER SHARE 36
NOTE 24 BORROWINGS 37
NOTE 25 NATURE AND LEVEL OF RISKS DERIVED FROM FINANCIAL INSTRUMENTS 38-41
NOTE 26 CASH AND CASH EQUIVALENTS 41
NOTE 27 SUBSEQUENT EVENTS 41

BESLER GIDA VE KİMYA SANAYİ VE TİCARET A.Ş. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION AS OF 30 SEPTEMBER 2025 AND 31 DECEMBER 2024

Unaudited Audited
Current Period Prior Period
30 September 31 December
Notes 2025 2024
ASSETS
Current Assets 22,813,368,509 20,504,631,438
Cash and cash equivalents 26 2,858,717,826 2,645,303,530
Trade receivables 5 4,696,858,263 4,443,385,260
- Trade receivables from related parties 4,5 2,435,705,911 2,390,919,365
- Trade receivables from third parties 5 2,261,152,352 2,052,465,895
Other receivables 6 9,257,439,149 7,899,011,747
- Other receivables from related parties 4,6 9,161,940,151 7,642,028,192
- Other receivables from third parties 6 95,498,998 256,983,555
Inventories 7 4,142,863,174 4,506,504,255
Prepaid expenses 8 1,197,754,683 482,825,833
- Prepaid expenses to related parties 4,8 535,146,362 160,022,546
-Prepaid expenses to third parties 8 662,608,321 322,803,287
Current income tax assets 22 252,619,034 220,716,169
Other current assets 15 407,116,380 306,884,644
Non-Current Assets 13,885,834,737 14,366,026,640
Other receivables 6 2,560,575 3,071,288
- Other receivables from third parties 6 2,560,575 3,071,288
Investment properties 9 3,367,817,060 3,367,817,060
Property, plant and equipment 10 9,817,897,861 10,111,955,652
Right of use assets 60,239,679 59,034,143
Intangible assets 11 416,945,435 371,074,555
Prepaid expenses 8 65,404,037 24,317,221
Deferred tax assets 22 154,970,090 428,756,721
TOTAL ASSETS 36,699,203,246 34,870,658,078

BESLER GIDA VE KİMYA SANAYİ VE TİCARET A.Ş. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION AS OF 30 SEPTEMBER 2025 AND 31 DECEMBER 2024

Unaudited Audited
Current Period Prior Period
30 September 31 December
Notes 2025 2024
LIABILITIES
Current Liabilities 16,466,803,104 14,803,020,664
Short-term borrowings 24 6,121,195,361 4,925,529,748
- Bank loans 24 6,080,585,379 4,824,090,355
- Lease liabilities 24 40,609,982 101,439,393
Current portion of long-term financial 631,217,437 138,483,296
liabilities 24
Trade payables 5 6,090,984,233 6,284,497,145
- Trade payables to related parties 4,5 54,686,122 76,105,768
- Trade payables to third parties 5 6,036,298,111 6,208,391,377
Other payables 6 2,354,090,103 1,874,856,712
- Other payables to related parties 4,6 2,354,088,277 1,874,854,423
- Other payables to third parties 6 1,826 2,289
Payables related to employee benefits 203,430,748 191,563,389
Deferred income 8 198,470,921 149,899,291
Current income tax liabilities 22 448,908,242 856,811,492
Short-term provisions 290,583,080 258,443,451
- Short-term provisions for employee benefits 259,850,994 250,189,887
- Other short-term provisions 13 30,732,086 8,253,564
Other current liabilities 15 127,922,979 122,936,140
Non-Current Liabilities 4,591,643,617 4,431,811,835
Long-term borrowings 24 1,763,494,056 1,260,303,313
- Bank loans 24 1,595,337,157 1,059,420,611
- Lease liabilities 24 168,156,899 200,882,702
Other payables 6 562,035,394 638,245,639
- Other payables to related parties 4,6 562,035,394 638,245,639
Long-term provisions 465,814,748 437,491,625
- Long-term provisions for employee benefits 465,814,748 437,491,625
Deferred income 8 4,561,009 14,014,915
Deferred tax liabilities 22 1,795,738,410 2,081,584,868
Other long term liabilities - 171,475
Total Liabilities 21,058,446,721 19,234,832,499

BESLER GIDA VE KİMYA SANAYİ VE TİCARET A.Ş. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION AS OF 30 SEPTEMBER 2025 AND 31 DECEMBER 2024

Unaudited Audited
Current Period Prior Period
30 September 31 December
Notes 2025 2024
EQUITY
Paid in capital 16 662,000,000 662,000,000
Share capital adjustment differences 5,938,797,299 5,938,797,299
Other comprehensive income or expenses are 3,558,714,153 3,495,179,813
not reclassified to profit or loss
- Gains on revaluation of plant, property and 3,788,058,799 3,724,524,459
equipment
- Losses on remeasurement of defined benefit (229,344,646) (229,344,646)
plans
Other comprehensive income or expenses to be 616,326,641 648,633,614
reclassified to profit or loss
- Currency translation differences 616,326,641 648,633,614
Share premium 809,028,190 809,028,190
Restricted reserves 16 724,553,593 724,553,593
Effect of business combinations under common (1,713,539,534) (1,713,539,534)
control
Retained earnings / (losses) 4,248,688,886 2,353,167,217
Net profit / (loss) for the year (5,269,265) 1,895,521,669
Equity holders of the parent 14,839,299,963 14,813,341,861
Non-controlling interests 801,456,562 822,483,718
Total Equity 15,640,756,525 15,635,825,579
TOTAL LIABILITIES AND EQUITY 36,699,203,246 34,870,658,078

BESLER GIDA VE KİMYA SANAYİ VE TİCARET A.Ş. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME FOR THE PERIODS ENDED 30 SEPTEMBER 2025 AND 2024

Note
s
Unaudited
Current Period
1 January -
30 September
2025
Unaudited
Prior Period
1 January -
30 September
2024
Unaudited
Current Period
1 July -
30 September
2025
Unaudited
Prior Period
1 July -
30 September
2024
Revenue 17 22,398,747,503 23,091,463,086 7,572,380,614 7,324,261,049
Cost of sales (-) 17 (17,176,947,339) (18,227,199,339) (5,966,441,430) (5,830,336,945)
Gross profit 5,221,800,164 4,864,263,747 1,605,939,184 1,493,924,104
General administrative expenses (-) 18 (761,325,733) (674,423,200) (251,374,223) (218,113,371)
Marketing expenses (-) 18 (2,386,483,692) (2,408,517,546) (747,667,780) (702,443,130)
Research and development expenses (-) 18 (51,033,046) (46,701,194) (14,344,507) (21,718,333)
Other income from operating activities 170,678,007 169,871,789 16,057,618 47,296,213
Other expenses from operating activities (-) (1,638,535,264) (1,424,779,637) (348,368,582) (478,284,198)
OPERATING PROFIT / (LOSS) 555,100,436 479,713,959 260,241,710 120,661,285
Income from investment activities 19 3,171,725,650 2,164,965,220 848,333,870 897,283,237
Investing activities expenses (-) 19 - (41,572,012) - (6,406,313)
OPERATING PROFIT / (LOSS) BEFORE
FINANCIAL INCOME / (EXPENSE)
3,726,826,086 2,603,107,167 1,108,575,580 1,011,538,209
Financial income 20 - 129,332,855 - 12,026,018
Financial expenses (-) 20 (3,009,235,814) (2,157,231,826) (900,565,505) (892,086,024)
Net monetary gain 21 (329,651,985) 646,170,059 129,070,119 427,213,867
PROFIT / (LOSS) BEFORE TAX FROM
CONTINUING OPERATIONS
387,938,287 1,221,378,255 337,080,194 558,692,070
Tax income / (expense) from continuing
operations
(448,419,785) 48,692,706 (192,079,907) (1,001,223)
- Current tax expense (-) 22 (392,120,897) (403,557,160) (159,513,082) (118,870,013)
- Deferred tax income / expense(-) 22 (56,298,888) 452,249,866 (32,566,825) 117,868,790
PROFIT / (LOSS) FOR THE YEAR (60,481,498) 1,270,070,961 145,000,287 557,690,847
Profit for the year attributable to:
Non-controlling interests (55,212,233) (37,947,715) (3,916,922) 15,572,270
Equity holders of the parent (5,269,265) 1,308,018,676 148,917,209 542,118,577
Earnings per share (TRY) 23 (0,0080) 1,9758 0,2250 0,8189
OTHER COMPREHENSIVE INCOME:
Items to not be reclassified subsequently to
profit or loss
67,109,512 (516,217,687) 17,881,076 (681,492,617)
- Gain on revaluation of property, plant and
equipment
- (69,874,088) - (153,450,069)
- Actuarial loss on defined benefit plans - - - -
- Other comprehensive (loss) / income not to be
reclassified to (loss) / profit, tax effect
67,109,512 (446,343,599) 17,881,076 (528,042,548)
Items to be reclassified subsequently to profit
or loss
(1,697,068) (40,399,893) (111,677,630) (44,676,832)
- Currency translation differences (1,697,068) (40,399,893) (111,677,630) (44,676,832)
Other Comprehensive Income / (Expense) 65,412,444 (556,617,580) (93,796,554) (726,169,449)
TOTAL COMPREHENSIVE INCOME /
(EXPENSE)
4,930,946 713,453,381 51,203,733 (168,478,602)
Total comprehensive income / (expense)
for the year attributable to:
Non-controlling interests (21,027,156) 16,413,662 (21,027,156) (24,741,238)
Equity holders of the parent 25,958,102 697,039,719 72,230,889 (143,737,364)

BESLER GIDA VE KİMYA SANAYİ VE TİCARET A.Ş. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDER'S EQUITY FOR THE PERIODS 30 SEPTEMBER 2025 AND 2024 (Amounts expressed in the purchasing power of the Turkish Lira ("TRY") as of 30 September 2025, unless otherwise indicated.)

Accumulated
other
comprehensive e
ated other income or
- ive income or expenses to be
- be reclassified reclassified to
to prof it or lose profit or lose _ Retained o earnings
Gains /
(losses) on Effect of
revaluation of Losses on business
Share capital plant, remeasurement Currency combinations Net profit / Non-
adjustment property, and of defined translation Share Restricted under common Retained (loss) for the Equity holders controlling
Paid in capital differences equipment benefit plans differences premium reserves control earnings year of the parent interests Total equity
Balances as of 1 January 2024 662,000,000 5,938,797,299 3,109,812,674 (196,574,610) 865,853,647 809,028,190 724,553,593 (1,713,539,534) 1,295,905,124 1,057,262,093 12,553,098,476 642,372,471 13,195,470,947
Transfers - - - - - - - - 1,057,262,093 (1,057,262,093) - - -
Total comprehensive income - - (516,217,687) - (94,761,270) - - - - 1,308,018,676 697,039,719 16,413,662 713,453,381
Balances as of 30 September 2024 662,000,000 5,938,797,299 2,593,594,987 (196,574,610) 771,092,377 809,028,190 724,553,593 (1,713,539,534) 2,353,167,217 1,308,018,676 13,250,138,195 658,786,133 13,908,924,328
Balances as of 1 January 2025 662,000,000 5,938,797,299 3,724,524,459 (229,344,646) 648,633,614 809,028,190 724,553,593 (1,713,539,534) 2,353,167,217 1,895,521,669 14,813,341,861 822,483,718 15,635,825,579
Transfers - - - - - - - - 1,895,521,669 (1,895,521,669) - - -
Total comprehensive Income - - 63,534,340 - (32,306,973) - - - - (5,269,265) 25,958,102 (21,027,156) 4,930,946
Balances as of 30 September 2025 662,000,000 5,938,797,299 3,788,058,799 (229,344,646) 616,326,641 809,028,190 724,553,593 (1,713,539,534) 4,248,688,886 (5,269,265) 14,839,299,963 801,456,562 15,640,756,525

BESLER GIDA VE KİMYA SANAYİ VE TİCARET A.Ş. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE PERIODS ENDED 30 SEPTEMBER 2025 AND 2024

Unaudited
Prior Period
1 January -
30 September
Unaudited
Prior Period
1 January -
30 September
Notes 2025 2024
Cash inflows / (outflows) from operating activities (1,555,278,095) 928,306,873
Profit for the year (60,481,498 1,270,070,961
Adjustments to reconcile profit / (loss) for the year 279,809,917 (752,693,614)
Adjustments related to depreciation and amortization expenses 11 550,689,118 514,324,558
Adjustments related to provision for/ (reversal) of impairment
loss 30,519,693 17,972,395
- Adjustments related to impairment loss on receivables 5 31,112,300 15,586,946
- Adjustments related to impairment (loss) / gain on
inventories, net 7 (592,607) 2,385,449
Adjustments related to provisions 381,485,039 399,212,244
- Adjustments related to provisions employee benefit 381,312,169 305,161,609
- Adjustments related to lawsuit provisions 172,870 456,495
- Other adjustments related to operations - 93,594,140
Adjustments related to interest and commission expenses /
(income) (665,313,535) (693,899,449)
- Adjustments related to interest and commission expense 20 1,517,026,944 1,415,635,389
- Adjustments related to interest income 19 (2,182,340,479) (2,109,534,838)
Adjustments related to unrealized currency translation
differences 20 470,992,226 738,165,095
Adjustments related to tax (income) / expense 22 448,419,785 (48,692,706)
Adjustments related to gain on disposal of non-current assets 19 (15,309,098) (5,110,037)
Adjustments for other items caused by cash flows arising from
investment or financing activities 66,781,260 (87,799,312)
Monetary gains / (losses) (988,454,571) (1,586,866,402)
Changes in working capital (789,856,420) 776,824,210
Changes in trade receivables 5 (284,585,303) 272,245,425
- Changes in trade receivables from non-related parties 5 (239,798,757) (71,194,288)
- Changes in trade receivables from related parties 4 (44,786,546) 343,439,713
Changes in inventories 7 364,233,688 1,296,178,561
Changes in other receivables related to operations (754,269,005) (15,324,789)
Changes in trade payables 5 (193,512,912) (1,552,731,827)
- Changes in trade payables from non-related parties 5 (172,093,266) (1,541,101,023)
- Changes in trade payables from related parties 4 (21,419,646) (11,630,804)
Changes in other payables related to operations 78,277,112 776,456,840
Cash generated / (used) from operations (570,528,001) 1,294,201,557
Cash outflow from paid in employee benefit provisions (152,823,082) (256,398,440)
Taxes paid (831,927,012) (109,496,244)

BESLER GIDA VE KİMYA SANAYİ VE TİCARET A.Ş. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE PERIODS ENDED 30 SEPTEMBER 2025 AND 2024

Unaudited Unaudited
Current Period Prior Period
1 January - 1 January -
30 September 30 September
Notes 2025 2024
Cash inflows / (outflows) from investing activities 2,905,394,626 1,965,149,511
Payments for purchase of property, plant and equipment and (295,453,264) (289,283,714)
intangible assets
- Payments for purchase of property, plant and equipment 10 (191,348,383) (199,477,813)
- Payments for purchase of intangible assets 11 (104,104,881) (89,805,901)
Proceeds from sale of property, plant and equipment and 10,11,19 44,431,338 94,578,042
intangible assets
Interest income from investment activities 19 2,182,340,479 2,109,534,838
Change in foreign currency from investing activities (net) 914,059,201 -
Rental income from investment properties 19 60,016,872 50,320,345
Cash inflows / (outflows) from financing activities (674,464,230) (2,891,661,573)
Cash inflows from loans 6,729,193,465 4,828,111,110
Cash outflows from repayment of borrowings (4,608,200,391) (2,223,056,751)
Payments of lease liabilities (94,760,750) (93,033,426)
Interest and commission paid 20 (1,517,026,944) (1,415,635,389)
Net increase / (decrease) in other payables to related parties 6 (1,183,669,610) (3,988,047,117)
Net decrease in cash and cash equivalents before the effect
of exchange rate changes 675,652,301 1,794,811
Effects of exchange rate changes on cash and cash equivalents (81,043,329) 162,139,274
Net change in cash and cash equivalents 594,608,972 163,934,085
Cash and cash equivalents at the beginning of the year 26 2,645,303,530 80,401,254
Inflation effect on cash and cash equivalents (381,194,676) (51,050,680)
Cash and cash equivalents at the end of the year 26 2,858,717,826 193,284,659

BESLER GIDA VE KİMYA SANAYİ VE TİCARET A.Ş. AND ITS SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 SEPTEMBER 2025

(Amounts expressed in the purchasing power of the Turkish Lira ("TRY") as of 30 September 2025, unless otherwise indicated.)

NOTE 1 - GROUP'S ORGANISATION AND NATURE OF OPERATIONS

Main operations of Besler Gıda ve Kimya Sanayi ve Ticaret A,Ş, (*) ("Besler" or "the Company") and its subsidiaries ("Group") are production and trading of frozen and canned vegetables and fruits, frozen pastry products, croquettes, canned tuna fish, edible oil and margarine, Products in the frozen product category; bakery products, vegetables and fruit products, potatoes and croquettes and meat products, Canned product categories; canned tuna, vegetables, and convenience foods, Besler was initially established in 1978, to export its sea food and has been one of the pioneer food companies since 1990 with "SuperFresh" brand.

Besler distributes frozen and canned products that are produced in Bursa and Afyon facilities throughout Türkiye through its dealers and own direct distribution channels, as well as exports its products, The Company has vegetables, fruits, seafood, tuna canned food, bakery products and pizza facilities in its Bursa factory, and has potato, vegetables and fruit production facilities in its Afyon factory.

Besler and its subsidiary Marsa has two production plants of oil and margarine in Pendik/İstanbul and in Adana, The third production plant of Besler was established by the end of 2017 in Sultanate of Brunei.

Donuk Fırıncılık (DFU) produces in its factory in Dudullu Organized Industrial Zone in the Frozen Bakery Products market and sells and markets it in all Türkiye and foreign markets.

The Company's registered office is in Kısıklı Mah, Ferah Cad, Yıldız Holding No:1/A Üsküdar İstanbul.

The ultimate shareholder of the Group is Yıldız Holding A,Ş.

The Company is registered to the Capital Markets Board ("CMB") and its shares have been quoted on the Borsa İstanbul A,Ş, ("BIST") since 1994.

As of 30 September 2025, and 31 December 2024, the principal shareholders and their respective shareholding rates in the Company are as follows:

30 September 2025 31 December 2024
(%) (%)
Yıldız Holding A,Ş, 60,53 60,53
Murat Ülker 9,98 9,98
Other 29,49 29,49
100 100

As of 30 September 2025, the number of employees employed by the Group is 2,126 (31 December 2024: 2,043).

(*) The Ordinary General Assembly resolutions of our company dated May 8, 2025, were registered and announced on May 16, 2025, and the trade name of our company has been changed to "BESLER GIDA VE KİMYA SANAYİ VE TİCARET ANONİM ŞİRKETİ"

BESLER GIDA VE KİMYA SANAYİ VE TİCARET A.Ş. AND ITS SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 SEPTEMBER 2025

(Amounts expressed in the purchasing power of the Turkish Lira ("TRY") as of 30 September 2025, unless otherwise indicated.)

NOTE 1 - GROUP'S ORGANISATION AND NATURE OF OPERATIONS (Continued)

The subsidiaries included in the scope of consolidation of the Group as of 30 September 2025 and 31 December 2024 and respective effective ownership rates are as follows:

Direct and Indirect Effective Ownership %
30 31
September December Countries
Subsidiaries 2025 2024 of activity Nature of business
Production and Trading of
Kerpe Gıda Sanayi ve Tic, A,Ş, 100 100 Türkiye Agricultural and Animal Products
Besmar Gıda Sanayi ve Ticaret Production and Trading of
A,Ş, 100 100 Türkiye Agricultural and Animal Products
Donuk Fırıncılık Ürünleri Production, Buying and Selling of
Sanayi ve Tic, A,Ş, 100 100 Türkiye Frozen Bakery Products
Berk Enerji Üretimi A,Ş, 88,17 88,17 Türkiye Generation of Electricity
Production and Trading of Oil
Marsa Yağ Sanayi ve Tic, A,Ş, 70 70 Türkiye and Oil Products
Western Foods and Pack, SDN Production and Trading of Oil
BHD (*) 70 70 Brunei and Oil Products

(*) The Group has indirect ownership,

Approval of the financial statements

The consolidated financial statements as of and for the period ended 30 September 2025 have been approved by the Board of Directors on October 10, 2025.

NOTE 2 - BASIS OF PRESENTATION OF CONSOLIDATED FINANCIAL STATEMENTS

2,1 - Basis of Presentation

Principles for Preparation of Financial Statements and Significant Accounting Policies

The accompanying consolidated financial statements are prepared in accordance with Communiqué Serial II, No:14,1, "Principles of Financial Reporting in Capital Markets" ("the Communiqué") published in the Official Gazette numbered 28676 on 13 September 2013, According to Article 5 of the Communiqué, consolidated financial statements are prepared in accordance with the Turkish Accounting Standards ("TAS") issued by Public Oversight Accounting and Auditing Standards Authority ("POA"), TAS contains Turkish Accounting Standards, Turkish Financial Reporting Standards ("TFRS") and its addendum and interpretations, In addition, the financial statements have been prepared in accordance with the "Announcement on TFRS Taxonomy" published by POA and the resolution of CMB about the Illustrations of Financial Statements and Application Guidance published on 4 October 2022.

BESLER GIDA VE KİMYA SANAYİ VE TİCARET A.Ş. AND ITS SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 SEPTEMBER 2025

(Amounts expressed in the purchasing power of the Turkish Lira ("TRY") as of 30 September 2025, unless otherwise indicated.)

NOTE 2 - BASIS OF PRESENTATION OF CONSOLIDATED FINANCIAL STATEMENTS (Continued)

2,1 Basis of Presentation (Continued)

Principles for Preparation of Consolidated Financial Statements and Significant Accounting Policies (Continued)

The condensed consolidated financial statements and notes of the Group have been presented in accordance with the formats announced by the Capital Markets Board (SPK) on 7 September, 2013, and include the required information.

The Company and Subsidiaries in Türkiye maintain their books of accounts and prepare their statutory financial statements in accordance with the Turkish Commercial Code ("TCC"), tax legislation, the Uniform Chart of Accounts issued by the Ministry of Finance and principles issued by CMB, The foreign subsidiaries maintain their books of account in accordance with the laws and regulations in force in the countries in which they are registered, The consolidated financial statements have been prepared under historical cost conventions except for land, buildings, derivatives, financial assets and financial liabilities which are carried at fair value.

The condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the accompanying notes for the year ended December 31, 2024.

Functional and Presentation Currency

The individual financial statements of each Group entity are prepared in the currency of the primary economic environment in which the entity operates (its functional currency), The results and financial position of each entity are expressed in TRY, which is the functional currency of the Company, and the presentation currency for the consolidated financial statements.

Financial Reporting in Hyperinflationary Economies

With the announcement made by the Public Oversight Accounting and Auditing Standards Authority (POA) on 23 November 2023, entities applying TFRSs have started to apply inflation accounting in accordance with TAS 29 Financial Reporting in Hyperinflationary Economies for the annual reporting period beginning on or after 31 December 2023, TAS 29 is applied to the financial statements, including the consolidated financial statements, of entities whose functional currency is the currency of a hyperinflationary economy.

In accordance with the standard, financial statements prepared in the currency of a hyperinflationary economy are stated in terms of the purchasing power of that currency at the balance sheet date, For comparative purposes, comparative information in the prior period financial statements is expressed in terms of the measuring unit current at the end of the reporting period, Therefore, the Group has presented its consolidated financial statements as at, 30 September 2024, 31 December 2024 in terms of the purchasing power of the currency as at 30 September 2025.

In accordance with the CMB's resolution No: 81/1820 dated 28 December 2023, issuers and capital market institutions subject to financial reporting regulations applying Turkish Accounting/Financial Reporting Standards are required to apply inflation accounting by applying the provisions of TAS 29 beginning with the annual financial statements for the accounting periods ending on 31 December 2023.

BESLER GIDA VE KİMYA SANAYİ VE TİCARET A.Ş. AND ITS SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 SEPTEMBER 2025

(Amounts expressed in the purchasing power of the Turkish Lira ("TRY") as of 30 September 2025, unless otherwise indicated.)

NOTE 2 - BASIS OF PRESENTATION OF CONSOLIDATED FINANCIAL STATEMENTS (Continued)

2,1 Basis of Presentation (Continued)

Financial Reporting in Hyperinflationary Economies (Continued)

The financial statements dated September 30, 2025, have been presented are adjusted for the inflation effect in accordance with the accounting principles specified in TAS 29.

The table below includes the inflation rates calculated based on the Consumer Price Index published by the Turkish Statistical Institute ("TÜİK") for the relevant periods:

Date Index Adjustment Coefficient Three-year cumulative
inflation rates
30 September 2025 3,367,22 1,00000 %222
31 December 2024 2,684,55 1,25429 %291
30 September 2024 2,526,16 1,33294 %343

The main components of the Group's restatement for financial reporting purposes in hyperinflationary economies are as follows:

  • The consolidated financial statements for the current period presented in TRY are expressed in terms of the purchasing power of TRY at the balance sheet date and the amounts for the previous reporting periods are adjusted and expressed in accordance with the purchasing power of TRY at the end of the reporting period.
  • Monetary assets and liabilities are not adjusted since they are currently expressed in terms of the purchasing power at the balance sheet date, Where the inflation-adjusted carrying amounts of nonmonetary items exceed their recoverable amounts or net realisable.
  • Non-monetary assets, liabilities and equity items that are not expressed in terms of the current purchasing power at the balance sheet date have been adjusted by using the relevant adjustment coefficients.
  • All items in the comprehensive income statement, except for the effect of non-monetary items in the balance sheet on the statement of comprehensive income, have been adjusted by applying the coefficients calculated over the periods in which the income and expense accounts were initially recognised in the financial statements.
  • The effect of inflation on the Group's net monetary asset position in the current period is recognised in the gain/(loss) on net monetary position in the consolidated income statement.

BESLER GIDA VE KİMYA SANAYİ VE TİCARET A.Ş. AND ITS SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 SEPTEMBER 2025

(Amounts expressed in the purchasing power of the Turkish Lira ("TRY") as of 30 September 2025, unless otherwise indicated.)

NOTE 2 - BASIS OF PRESENTATION OF CONSOLIDATED FINANCIAL STATEMENTS (Continued)

2,1 Basis of Presentation (Continued)

Basis of Consolidation

(a) Subsidiaries

Subsidiaries are all entities over which the Group has control, The Group controls an entity when the Group is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power over the entity, Subsidiaries are fully consolidated from the date on which control is transferred to the Group, They are deconsolidated from the date that control ceases.

Inter-Group transactions, balances, and unrealized gains on transactions between group companies are eliminated, Unrealized losses are also eliminated.

(b) Changes in ownership interests in subsidiaries without change of control

Changes in the Group's ownership interests in subsidiaries that do not result in the loss of control over the subsidiaries are accounted for as equity transactions. The carrying amounts of the Group's interests and the noncontrolling interests are adjusted to reflect the changes in their relative interests in the subsidiaries. Any difference between the amount by which the non-controlling interests are adjusted and the fair value of the consideration paid or received is recorded directly in equity as the Group's share.

(c) Loss of subsidiary control

When the Group loses control of a subsidiary, a gain or loss is recognized in profit or loss and is calculated as the difference between (i) the aggregate of the fair value of the consideration received and the fair value of any retained interest and (ii) the previous carrying amount of the assets (including goodwill), and liabilities of the subsidiary and any non-controlling interests, All amounts previously recognized in other comprehensive income in relation to that subsidiary are accounted for as if the Group had directly disposed of the related assets or liabilities of the subsidiary (i,e, reclassified to profit or loss or transferred to another category of equity as specified/permitted by applicable TFRS), The fair value of any investment retained in the former subsidiary at the date when control is lost is regarded as the fair value on initial recognition for subsequent accounting under TFRS 9, when applicable, the cost on initial recognition of an investment in an associate or a joint venture.

2.2 New and Amended Turkish Financial Reporting Standards

The accounting policies adopted in preparation of the consolidated financial statements as of September 30, 2025 are consistent with those of the previous financial year, except for the adoption of new and amended TFRS and TFRS interpretations effective as of January 1, 2024 and thereafter, The effects of these standards and interpretations on the Group's financial position and performance have been disclosed in the related paragraphs.

i) Standards, amendments, and interpretations applicable as of 30 September 2025:

Amendment to IAS 1 - Non-current liabilities with covenants; effective from annual periods beginning on or after 1 January 2024, These amendments clarify how conditions with which an entity must comply within twelve months after the reporting period affect the classification of a liability, The amendments also aim to improve information an entity provides related to liabilities subject to these conditions.

BESLER GIDA VE KİMYA SANAYİ VE TİCARET A.Ş. AND ITS SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 SEPTEMBER 2025

(Amounts expressed in the purchasing power of the Turkish Lira ("TRY") as of 30 September 2025, unless otherwise indicated.)

NOTE 2 - BASIS OF PRESENTATION OF CONSOLIDATED FINANCIAL STATEMENTS (Continued)

2,2 New and Amended Turkish Financial Reporting Standards (Continued)

Amendment to IFRS 16 - Leases on sale and leaseback; effective from annual periods beginning on or after 1 January 2024, These amendments include requirements for sale and leaseback transactions in IFRS 16 to explain how an entity accounts for a sale and leaseback after the date of the transaction, Sale and leaseback transactions where some or all the lease payments are variable lease payments that do not depend on an index or rate are most likely to be impacted.

Amendments to IAS 7 and IFRS 7 on Supplier finance arrangements; effective from annual periods beginning on or after 1 January 2024, These amendments require disclosures to enhance the transparency of supplier finance arrangements and their effects on a company's liabilities, cash flows and exposure to liquidity risk, The disclosure requirements are the IASB's response to investors' concerns that some companies' supplier finance arrangements are not sufficiently visible, hindering investors' analysis.

ii) Standards, amendments, and interpretations that are issued but not effective as of 30 September 2025:

Amendments to IAS 21 - Lack of Exchangeability; effective from annual periods beginning on or after 1 January 2025, An entity is impacted by the amendments when it has a transaction or an operation in a foreign currency that is not exchangeable into another currency at a measurement date for a specified purpose, A currency is exchangeable when there is an ability to obtain the other currency (with a normal administrative delay), and the transaction would take place through a market or exchange mechanism that creates enforceable rights and obligations.

Amendment to IFRS 9 and IFRS 7 - Classification and Measurement of Financial Instruments; effective from annual reporting periods beginning on or after 1 January 2026 (early adoption is available), These amendments:

  • Clarify the requirements for the timing of recognition and derecognition of some financial assets and liabilities, with a new exception for some financial liabilities settled through an electronic cash transfer system
  • Clarify and add further guidance for assessing whether a financial asset meets the solely payments of principal and interest (SPPI) criterion.
  • Add new disclosures for certain instruments with contractual terms that can change cash flows (such as some instruments with features linked to the achievement of environment, social and governance (ESG) targets); and
  • Make updates to the disclosures for equity instruments designated at Fair Value through Other Comprehensive Income (FVOCI).

BESLER GIDA VE KİMYA SANAYİ VE TİCARET A.Ş. AND ITS SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 SEPTEMBER 2025

(Amounts expressed in the purchasing power of the Turkish Lira ("TRY") as of 30 September 2025, unless otherwise indicated.)

NOTE 2 - BASIS OF PRESENTATION OF CONSOLIDATED FINANCIAL STATEMENTS (Continued)

2,2 New and Amended Turkish Financial Reporting Standards (Continued)

Annual improvements to IFRS – Volume 11; Annual improvements are limited to changes that either clarify the wording in an Accounting Standard or correct relatively minor unintended consequences, oversights or conflicts between the requirements in the Accounting Standards, The 2024 amendments are to the following standards:

  • IFRS 1 First-time Adoption of International Financial Reporting Standards;
  • IFRS 7 Financial Instruments: Disclosures and its accompanying Guidance on implementing IFRS 7;
  • IFRS 9 Financial Instruments;
  • IFRS 10 Consolidated Financial Statements; and
  • IAS 7 Statement of Cash Flows.

Amendment to IFRS 9 and IFRS 7 - Contracts Referencing Nature-dependent Electricity; effective from annual periods beginning on or after 1 January 2026 but can be early adopted subject to local endorsement where required, These amendments change the 'own use' and hedge accounting requirements of IFRS 9 and include targeted disclosure requirements to IFRS 7, These amendments apply only to contracts that expose an entity to variability in the underlying amount of electricity because the source of its generation depends on uncontrollable natural conditions (such as the weather), These are described as 'contracts referencing nature-dependent electricity.

IFRS 18 Presentation and Disclosure in Financial Statements; effective from annual periods beginning on or after 1 January 2027,This is the new standard on presentation and disclosure in financial statements, with a focus on updates to the statement of profit or loss, The key new concepts introduced in IFRS 18 relate to:

  • The structure of the statement of profit or loss;
  • Required disclosures in the financial statements for certain profit or loss performance measures that are reported outside an entity's financial statements (that is, management-defined performance measures); and
  • Enhanced principles on aggregation and disaggregation which apply to the primary financial statements and notes in general.

IFRS 19 Subsidiaries without Public Accountability: Disclosures; effective from annual periods beginning on or after 1 January 2027,This new standard works alongside other IFRS Accounting Standards, An eligible subsidiary applies the requirements in other IFRS Accounting Standards except for the disclosure requirements and instead applies the reduced disclosure requirements in IFRS 19, IFRS 19's reduced disclosure requirements balance the information needs of the users of eligible subsidiaries' financial statements with cost savings for preparers, IFRS 19 is a voluntary standard for eligible subsidiaries, A subsidiary is eligible if:

  • It does not have public accountability; and
  • It has an ultimate or intermediate parent that produces consolidated financial statements available for public use that comply with IFRS Accounting Standards.

BESLER GIDA VE KİMYA SANAYİ VE TİCARET A.Ş. AND ITS SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 SEPTEMBER 2025

(Amounts expressed in the purchasing power of the Turkish Lira ("TRY") as of 30 September 2025, unless otherwise indicated.)

NOTE 3 - SEGMENT REPORTING

Established in Türkiye, the Group's field of activity is the production and trade of frozen and canned fruits and vegetables, frozen and canned sea products, frozen bakery products, croquet, canned tuna fish, oil and margarine, Operating segments are determined and reported in a manner consistent with the reporting provided to the Board of Directors and their strategic decision-making processes.

The Board of Directors and top management monitor the operations of the Group based on the different business units, which are "frozen and canned food" and "edible oil",

The segment revenues and expenses for the periods 1 January - 30 September 2025 and 1 January - 30 September 2024 are as follows:

1 January
Frozen and Canned Edible Oil 30 September 2025
Revenue 8,378,434,408 14,020,313,095 22,398,747,503
Gross Profit 2,618,743,103 2,603,057,061 5,221,800,164
Operating Profit 890,377,280 1,132,580,413 2,022,957,693
EBITDA (*) 1,257,156,546 1,316,490,265 2,573,646,811
EBITDA/Revenue 15,0% 9,4% 11,5%
Investment 232,661,229 62,792,035 295,453,264
1 January
Frozen and Canned Edible Oil 30 September 2024
Revenue 8,479,155,322 14,612,307,764 23,091,463,086
2,382,200,117 2,482,063,630 4,864,263,747
Gross Profit 773,944,301 960,677,506 1,734,621,807
Operating Profit 1,122,196,035 1,126,750,330 2,248,946,365
EBITDA (*)
EBITDA/Revenue
13,2% 7,7% 9,7%

(*) EBITDA is not a measurement instrument that is prescribed in TAS and it cannot be comparable other entities calculations.

NOTE 4 - RELATED PARTY DISCLOSURES

Due to related parties, due from related parties and summary of significant transactions with related parties as of 30 September 2025 and 31 December 2024 are as follows.

The related parties listed below are composed of Yıldız Holding group companies.

30 September 31 December
Trade receivables from related parties 2025 2024
Ülker Bisküvi San, A,Ş, 733,364,906 683,735,291
G2mEksper Satış ve Dağıtım Hizmetleri A,Ş, 470,325,895 489,239,543
Şok Marketler Tic, A,Ş, 378,717,760 369,655,812
Yeni Teközel Markalı Ürünler Dağıtım Hizmetleri A,Ş, 375,149,764 400,798,124
Horizon Hızlı Tüketim Ürünleri Paz. Sat. ve Dağ. A.Ş. 212,935,269 175,046,312
Bizim Toptan Satış Mağazaları A,Ş, 167,484,355 204,481,119
E Star GLobal E Ticaret Satış ve Pazarlama A.Ş. 46,549,638 40,286,685
Pladis Foods Ltd, 40,770,893 23,395,188
CCC Dış Ticaret A.Ş. 4,515,622 -
Other 5,891,809 4,281,291
Total 2,435,705,911 2,390,919,365

BESLER GIDA VE KİMYA SANAYİ VE TİCARET A.Ş. AND ITS SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 SEPTEMBER 2025

(Amounts expressed in the purchasing power of the Turkish Lira ("TRY") as of 30 September 2025, unless otherwise indicated.)

NOTE 4 - RELATED PARTY DISCLOSURES (Continued)

30 September 31 December
Trade payables to related parties 2025 2024
Aytaç Gıda Yatırım San. Tic. A.Ş. 19,151,282 4,022,266
İzsal Bilgi Sistemleri Ve Gayrimenkul Geliştirme A.Ş 18,573,292 38,962,062
Ucz Mağazacılık Tic, A,Ş, 5,063,321 -
Ülker Bisküvi San, A,Ş, 3,924,750 4,676,336
G2mEksper Satış ve Dağıtım Hizmetleri A,Ş, 3,467,869 12,415,717
Sağlam İnşaat Taahhüt Tic, A,Ş, 1,872,737 3,556,728
Penta Teknoloji Ürünleri Dağıtım Tic, A,Ş, 54,971 2,955,361
Northstar Innovation A,Ş, 38,250 1,794,605
Adapazarı Şeker Fabrikası A,Ş, - 2,205,482
Other 2,539,650 5,517,211
Total 54,686,122 76,105,768

Due from related parties and due to related parties' balances comprised of purchasing and selling goods and services, Supply of goods comprise of mainly purchases of raw materials.

30 September 31 December
Other receivables from related parties 2025 2024
Maia International B,V, 6,699,362,413 -
Yıldız Holding A,Ş,(*) 2,462,577,738 7,642,028,192
9,161,940,151 7,642,028,192
30 September 31 December
Other payables to related parties 2025 2024
Yıldız Holding A,Ş,(*) 2,354,088,277 1,874,854,423
2,354,088,277 1,874,854,423
30 September 31 December
Other non-current payables to related parties 2025 2024
Yıldız Holding A,Ş,(**) 562,035,394 638,245,639
562,035,394 638,245,639
  • (*) The relevant amount consists of balances made available from releated parties and to releated parties for financing purposes, and these balances do not have a certain maturity, Interest rates are re-determined on a monthly basis, taking into account market conditions, and as of 30 September 2025, the average interest rates of TRY-based receivables and payables are 45,89%, the average interest rates of EUR-based receivables are 6,35%, (31 December 2024: TRY 48,71%).
  • (**) As of 12 July 2018, Yıldız Holding A,Ş and some Yıldız Holding Group entities including Group, signed a syndicated loan agreement with creditors, Thus, the Group's borrowings to banks were transferred to Yıldız Holding, Total of the long-term payables of the Group to Yıldız Holding is composed of syndicated debts.

The amount of collateral given as guarantor ship and mortgage within the scope of the syndication debts is TRY11,619,036,898 (31 December 2024: TRY13,648,769,585).

BESLER GIDA VE KİMYA SANAYİ VE TİCARET A.Ş. AND ITS SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 SEPTEMBER 2025

(Amounts expressed in the purchasing power of the Turkish Lira ("TRY") as of 30 September 2025, unless otherwise indicated.)

NOTE 4 - RELATED PARTY DISCLOSURES (Continued)

Sale of goods and services 1 January -
30 September
2025
1 January -
30 September
2024
1 July -
30 September
2025
1 July -
30 September
2024
Ülker Bisküvi San, A,Ş, 3,948,641,083 3,768,422,469 1,431,526,892 960,247,621
Yeni Teközel Markalı Ürünler Dağıtım Hizmetleri A,Ş, 1,406,433,090 1,577,924,515 465,902,911 430,354,644
G2MEKSPER Satış ve Dağıtım Hizmetleri A,Ş, 1,347,927,578 1,266,832,484 504,269,420 484,491,907
Şok Marketler Ticaret A,Ş, 1,240,891,506 940,156,249 367,540,045 337,319,877
Horizon Hızlı Tüketim Ürünleri Paz. Sat. ve Dağ. A.Ş 743,359,928 744,253,404 262,246,581 220,844,109
Bizim Toptan Satış Mağazaları A,Ş, 292,624,263 348,267,171 120,250,917 127,087,972
Other 117,883,541 317,977,289 37,973,043 56,820,575
9,097,760,989 8,963,833,581 3,189,709,809 2,617,166,705
1 January - 1 January - 1 July – 1 July –
30 September 30 September 30 September 30 September
Purchase of goods and services 2025 2024 2025 2024
Maia International B,V, 2,060,286,041 2,746,843,936 432,960,711 280,028,395
Yıldız Holding A,Ş, 316,695,254 257,874,320 70,647,848 63,619,951
İzsal Bilgi Sistemleri Ve Gayrimenkul Geliştirme A.Şs 173,128,143 148,302,751 50,493,117 50,510,178
Aytaç Gıda Yatırım San, Tic, A,Ş, 69,473,469 76,328,662 23,906,722 11,426,434
Sağlam İnşaat Taahhüt Tic, A,Ş, 38,267,424 35,391,618 11,901,565 11,089,722
Horizon Hızlı Tüketim Ürünleri Paz. Sat. ve Dağ. A.Ş. 29,620,903 22,145,083 25,000,014 4,663,353
Ülker Bisküvi San, A,Ş, 24,396,190 382,362,281 9,986,214 374,735,196
Other 48,077,974 24,139,913 11,614,255 2,963,404
2,759,945,398 3,693,388,564 636,510,446 799,036,633
1 January - 1 January - 1 July - 1 July -
30 September 30 September 30 September 30 September
Service, rent and other income 2025 2024 2025 2024
Yıldız Holding A,Ş, 6,120,701 4,457,072 1,578,869 304,059
Sağlam İnşaat Taahhüt Tic, A,Ş, 1,060,993 946,198 329,555 259,136
G2mEksper Satış ve Dağıtım Hizmetleri A,Ş, 1,047,925 161,696 271,149 161,696
Bizim Toptan Satış Mağazaları A,Ş, 1,010,323 1,736,172 316,232 1,091,335
Şok Marketler Ticaret A.Ş, 51,917 2,005,078 - 1,632,893
Horizon Hızlı Tüketim Ürünleri A.Ş 18,361 3,935,435 15,490 3,455,586
Other 63,214 3,028,579 63,214 2,855,528
9,373,434 16,270,230 2,574,509 9,760,233

BESLER GIDA VE KİMYA SANAYİ VE TİCARET A.Ş. AND ITS SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 SEPTEMBER 2025

(Amounts expressed in the purchasing power of the Turkish Lira ("TRY") as of 30 September 2025, unless otherwise indicated.)

NOTE 4 - RELATED PARTY DISCLOSURES (Continued)

Interest and foreign exchange expense 1 January -
30 September
2025
1 January -
30 September
2024
1 July -
30 September
2025
1 July -
30 September
2024
Yıldız Holding A,Ş, 621,555,982 388,301,967 284,313,076 79,703,802
Pervin Finansal Kiralama A,Ş, 21,188,569 24,588,313 6,487,616 13,092,526
Ülker Bisküvi San, A,Ş, 93,729,721 - 40,842,796 -
Other 1,590,800 65,696 1,362,738 65,697
738,065,072 412,955,976 333,006,226 92,862,025
Commission and financial income 1 January -
30 September
2025
1 January-
30 September
2024
1 July -
30
September
2025
1 July -
30
September
2024
Ülker Bisküvi San, A,Ş, 202,979,246 - 67,522,856 -
Horizon Hızlı Tüketim Ürünleri Paz. Sat. ve Dağ. A.Ş. 2,174,972 133,466 199,093 -
Bizim Toptan Satış Mağazaları A,Ş, 1,915,605 - - -
Other 910,186 - 155,435 -
207,980,009 133,466 67,877,384 -
Investment income 1 January -
30 September
2025
1 January-
30 September
2024
1 July -
30 September
2025
1 July -
30 September
2024
Yıldız Holding A,Ş, (*) 1,908,407,769 1,340,612,819 341,229,632 176,073,825
Maia International B,V, 918,030,063 - 389,963,679 -
2,826,437,832 1,340,612,819 731,193,311 176,073,825

(*) Income from investment activities obtained from Yıldız Holding comprised of interest and exchange differences.

Prepaid expenses to related parties 30 September
2025
31 December
2024
Maia International B.V. (*) 535,146,362 160,022,546
535,146,362 160,022,546

(*) The related amounts consist of order advances given to related parties.

BESLER GIDA VE KİMYA SANAYİ VE TİCARET A.Ş. AND ITS SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 SEPTEMBER 2025

(Amounts expressed in the purchasing power of the Turkish Lira ("TRY") as of 30 September 2025, unless otherwise indicated.)

NOTE 4 - RELATED PARTY DISCLOSURES (Continued)

Key management compensation:

Key management personnel of the Company consist of the members of Board of Directors and members of Executive Board, The compensation of key management personnel comprises salaries, bonus, health insurance and transportation, The compensation of key management during the years are as follows:

1 January - 1 January -
30 September
1 July -
30 September
1 July -
30 September
30 September 2025 2024 2025 2024
Salaries and other benefits 160,539,158 146,787,587 32,144,971 37,394,754
160,539,158 146,787,587 32,144,971 37,394,754

NOTE 5- TRADE RECEIVABLES AND PAYABLES ( Continued)

As of 30 September 2025 and 31 December 2024 trade receivables of the Group are as follows:

30 September 31 December
Current trade receivables 2025 2024
Trade receivables (*) 2,321,224,222 2,095,320,674
Notes receivable 21,280,286 24,305,039
Income accruals 13,520 1,523,242
Provision for doubtful receivables (-) (81,365,676) (68,683,060)
Trade receivables, net 2,261,152,352 2,052,465,895
Trade receivables from related parties (Note 4) (**) 2,435,705,911 2,390,919,365
4,696,858,263 4,443,385,260

(*) Progress accruals arising from sales to customers are netted off with trade receivables,

Average maturity for trade receivables is 55 days (31 December 2024: 53).

(**) Trade receivables from related parties mainly comprised from sales of goods, Purchases are mainly comprised of purchases of raw materials.

BESLER GIDA VE KİMYA SANAYİ VE TİCARET A.Ş. AND ITS SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 SEPTEMBER 2025

(Amounts expressed in the purchasing power of the Turkish Lira ("TRY") as of 30 September 2025, unless otherwise indicated.)

NOTE 5- TRADE RECEIVABLES AND PAYABLES

Movements of provision for doubtful receivables as of 1 January - 30 September 2025 and 1 January - 30 September 2024 are as follows:

1 January - 1 January -
Movement of provision for doubtful receivables 30 September 2025 30 September 2024
Opening balance (68,683,060) (84,700,521)
Charge for the year (-) (32,048,786) (16,819,914)
Reversals of provisions 936,486 1,232,968
Monetary gain / (loss) 18,429,684 26,391,484
End of the period (81,365,676) (73,895,983)
Short-term trade payables 30 September
2025
31 December
2024
Trade payables 5,879,612,256 6,032,280,076
Expense accruals 156,685,855 176,111,301
Trade payables, net 6,036,298,111 6,208,391,377
Trade payables to related parties (Note 4) (*) 54,686,122 76,105,768
6,090,984,233 6,284,497,145

(*) Trade payables to related parties mainly comprised from purchases of goods and services, Purchases are mainly comprised of purchases of raw materials.

Average maturity for trade payables is 97 days (31 December 2024: 101).

BESLER GIDA VE KİMYA SANAYİ VE TİCARET A.Ş. AND ITS SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 SEPTEMBER 2025

(Amounts expressed in the purchasing power of the Turkish Lira ("TRY") as of 30 September 2025, unless otherwise indicated.)

NOTE 6 - OTHER RECEIVABLES AND PAYABLES

Other Receivables

30 September 31 December
Other current receivables 2025 2024
Receivables from related parties (Note 4) 9,161,940,151 7,642,028,192
Receivables from tax administration 88,642,631 247,921,590
Other miscellaneous receivables 6,856,367 9,061,965
9,257,439,149 7,899,011,747
30 September 31 December
Other non-current receivables 2025 2024
Deposits and guarantees given 2,560,575 3,071,288
2,560,575 3,071,288
Other Payables
30 September 31 December
Other current liabilities 2025 2024
Payables to related parties (Note 4) 2,354,088,277 1,874,854,423
Other miscellaneous liabilities 1,826 2,289
2,354,090,103 1,874,856,712
30 September 31 December
Other non-current liabilities 2025 2024
Non-current liabilities to related parties (Note 4) 562,035,394 638,245,639

NOTE 7 - INVENTORIES

30 September 31 December
2025 2024
Raw materials 1,605,233,751 2,085,473,555
Work in process 1,487,412,102 1,358,813,671
Finished goods 785,589,567 781,845,652
Trade goods 58,829,482 112,621,248
Other inventory (*) 205,798,272 168,342,736
Provision for impairment of inventory (-) - (592,607)
4,142,863,174 4,506,504,255

562,035,394 638,245,639

Movements of provision for impairment of inventories as of 1 January - 30 September 2025 and 1 January - 30 September 2024 are as follows:

1 January - 1 January -
30 September 2025 30 September 2024
Opening balance (592,607) (2,910,062)
Charge for the year - (4,665,747)
Reversals of provisions during the period 592,607 2,280,298
Closing balance - (5,295,511)

(*) Other inventories consist of packaging and technical operating materials.

BESLER GIDA VE KİMYA SANAYİ VE TİCARET A.Ş. AND ITS SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 SEPTEMBER 2025

(Amounts expressed in the purchasing power of the Turkish Lira ("TRY") as of 30 September 2025, unless otherwise indicated.)

NOTE 8 - PREPAID EXPENSES AND DEFERRED REVENUE

30 September 31 December
Short-term prepaid expenses 2025 2024
Advances given for inventory purchases 505,376,507 186,321,914
Prepaid expenses 156,491,227 136,231,481
Business advances 740,587 249,892
Prepaid expenses to third parties 662,608,321 322,803,287
Prepaid expenses to related parties (Note 4) 535,146,362 160,022,546
1,197,754,683 482,825,833
30 September 31 December
Long-term prepaid expenses 2025 2024
Advances given for fixed asset purchases 65,404,037 24,317,221
65,404,037 24,317,221
30 September 31 December
Short-term deferred income 2025 2024
Advances received 194,801,502 145,920,333
Deferred income 3,669,419 3,978,958
198,470,921 149,899,291
30 September 31 December
Long-term deferred income 2025 2024
Deferred income 4,561,009 14,014,915
4,561,009 14,014,915

NOTE 9 - INVESTMENT PROPERTIES

Cost value 1 January 2025 Disposals Transfers Change in fair value 30 September 2025
Land, building, plant
machinery and devices
3,367,817,060 - - - 3,367,817,060
3,367,817,060 - - - 3,367,817,060
Cost value 1 January 2024 Disposals Transfers Change in fair value 30 September 2024
Land, building, plant
machinery and
devices
2,404,478,166 - - - 2,404,478,166
2,404,478,166 - - - 2,404,478,166

The Group has earned rent income from its investment properties amounting to TRY60,016,872 in the current period, (1 January - 30 September 2024: TRY50,320,345) (Note 19).

BESLER GIDA VE KİMYA SANAYİ VE TİCARET A.Ş. AND ITS SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 SEPTEMBER 2025

(Amounts expressed in the purchasing power of the Turkish Lira ("TRY") as of 30 September 2025, unless otherwise indicated.)

NOTE 9 - INVESTMENT PROPERTIES (Continued)

Fair value of investment properties

30 September 2025
Level 1 Level 2 Level 3
Investment properties - 3,367,817,060 -
Total - 3,367,817,060 -
30 September 2024
Level 1 Level 2 Level 3
Investment properties - 2,404,478,166 -

Total - 2,404,478,166 -

As of 30 September 2025, the Group's investment properties are carried with their fair values determined by the revaluation carried out on 31 December 2024, and these fair values have been determined by an independent valuation firm holding a CMB License, The change between the fair value and cost value of the investment properties at initial recognition is included under equity, Gains or losses arising from changes in fair value in subsequent measurement periods are included in the consolidated statement of profit or loss.

The table above present the fair value hierarchy of investment properties of the Group as of 30 September 2025 and 31 December 2024, The levels of hierarchies of fair values are detailed below.

  • Level 1: Quoted prices in active markets for identical assets or liabilities,
  • Level 2: Inputs other than quoted prices included within level 1 that are observable for the asset or liability, either directly or indirectly,
  • Level 3: Inputs for the asset or liability that are not based on observable market data

Valuation techniques used to derive level 2 fair values.

Level 2 fair values of investment properties have been derived using the sales comparison approach, Sales prices of comparable land and buildings in proximity are adjusted for differences in key attributes such as property size, The most significant input into this valuation approach is price per square foot.

BESLER GIDA VE KİMYA SANAYİ VE TİCARET A.Ş. AND ITS SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 SEPTEMBER 2025 (Amounts expressed in the purchasing power of the Turkish Lira ("TRY") as of 30 September 2025, unless otherwise indicated.)

NOTE 10 - PROPERTY, PLANT AND EQUIPMENT

1 January Currency
translation
30 September
Cost value 2025 Additions Disposals Transfers differences 2025
Land and land improvements 4,371,176,134 - - - 6,641 4,371,182,775
Buildings 5,072,781,728 - (77,916,700) - 16,569,445 5,011,434,473
Machinery and equipment 7,352,167,154 70,940,645 (743,975) - 3,987,348 7,426,351,172
Motor vehicles 26,229,497 1,310 - - 45,246 26,276,053
Furniture and fixtures 670,988,314 17,309,423 (1,229,795) - 365,706 687,433,648
Leasehold improvements 75,720,932 - - - - 75,720,932
Other tangibles (*) 456,762,871 12,946 (14,761,446) - - 442,014,371
Construction in progress 5,464,162 103,084,059 - - - 108,548,221
18,031,290,792 191,348,383 (94,651,916) - 20,974,386 18,148,961,645
1 January Currency
translation
30 September
Accumulated depreciation 2025 Additions Disposals Transfers differences 2025
Land improvements (18,451,327) (1,475,672) - - (4,480) (19,931,479)
Buildings (1,925,143,472) (121,851,321) 51,073,442 - (3,435,157) (1,999,356,508)
Machinery and equipment (5,112,949,578) (285,040,248) 743,975 - (2,818,078) (5,400,063,929)
Motor vehicles (23,100,436) (2,916,592) - - (63,748) (26,080,776)
Furniture and fixtures (500,904,893) (32,853,032) 763,445 - (272,480) (533,266,960)
Leasehold improvements (59,700,090) (3,724,831) - - - (63,424,921)
Other tangibles (*) (279,085,344) (22,802,681) 12,948,814 - - (288,939,211)
(7,919,335,140) (470,664,377) 65,529,676 - (6,593,943) (8,331,063,784)
Net book value 10,111,955,652 9,817,897,861
---------------- ---------------- ---------------

(*) Other tangibles comprised of refrigerators,

BESLER GIDA VE KİMYA SANAYİ VE TİCARET A.Ş. AND ITS SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 SEPTEMBER 2025 (Amounts expressed in the purchasing power of the Turkish Lira ("TRY") as of 30 September 2025, unless otherwise indicated.)

NOTE 10 - PROPERTY, PLANT AND EQUIPMENT (Continued)

1 January Currency 30 September
Cost value 2024 Additions Disposals Transfers translation differences 2024
Land and land improvements 3,311,496,433 - - - 7,419 3,311,503,852
Buildings 5,590,746,680 4,574,541 (54,507,594) 101,625,363 (198,608,713) 5,443,830,277
Machinery and equipment 7,175,108,402 105,635,091 (78,538,058) 4,120,575 (100,707,974) 7,105,618,036
Motor vehicles 27,153,458 - - - (570,349) 26,583,109
Furniture and fixtures 682,549,836 16,836,540 (37,250,010) 517,774 (14,640,794) 648,013,346
Leasehold improvements 72,586,159 3,134,773 - - - 75,720,932
Other tangibles (*) 469,776,938 296,283 (27,031,302) - - 443,041,919
Construction in progress 2,411,035 69,000,585 - (4,638,349) - 66,773,271
17,331,828,941 199,477,813 (197,326,964) 101,625,363 (314,520,411) 17,121,084,742
1 January Currency 30 September
2024
(51,453,739)
(1,819,989,860) (116,322,028) - - 24,812,908 (1,911,498,980)
(4,849,822,599) (286,416,125) 78,331,786 - 106,838,996 (4,951,067,942)
(24,130,106) (67,421) - - 574,938 (23,622,589)
(470,638,736) (34,528,855) 6,383,274 - 4,519,436 (494,264,881)
(54,378,374) (3,952,019) - - - (58,330,393)
(278,683,655) (20,015,230) 23,143,899 - - (275,554,986)
(7,540,866,954) (471,931,246) 107,858,959 - 139,145,731 (7,765,793,510)
2024
(43,223,624)
Additions
(10,629,568)
Disposals
-
Transfers
-
translation differences
2,399,453
Net Book Value 9,790,961,987 9,355,291,232
---------------- --------------- ---------------

(*) Other tangible assets consist of refrigerated cabinets.

BESLER GIDA VE KİMYA SANAYİ VE TİCARET A.Ş. AND ITS SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 SEPTEMBER 2025

(Amounts expressed in the purchasing power of the Turkish Lira ("TRY") as of 30 September 2025, unless otherwise indicated.)

NOTE 11 - INTANGIBLE ASSETS

Currency
1 January translation 30 September
Cost value 2025 Additions Disposals Transfers differences 2025
Rights 271,953,057 24,510,007 - - 249,870 296,712,934
Development expenses 606,972,227 79,594,874 - - - 686,567,101
Other intangible assets 8,561,998 - - - - 8,561,998
887,487,282 104,104,881 - - 249,870 991,842,033
Currency
Accumulated 1 January translation 30 September
amortization 2025 Additions Disposals Transfers differences 2025
Rights (201,953,515) (12,126,557) - - (46,538) (214,126,610)
Development expenses (305,897,405) (46,310,776) - - - (352,208,181)
Other intangible assets (8,561,807) - - - - (8,561,807)
(516,412,727) (58,437,333) - - (46,538) (574,896,598)
Net Book Value 371,074,555 416,945,435
---------------- ------------- -------------
Currency
1 January translation 30 September
Cost value 2024 Additions Disposals Transfers differences 2024
Rights 347,384,060 25,932,702 - (101,625,363) (1,193,415) 270,497,984
Development expenses 513,353,408 63,873,199 - - - 577,226,607
Other intangible assets 8,561,998 - - - - 8,561,998
869,299,466 89,805,901 - (101,625,363) (1,193,415) 856,286,589
Accumulated 1 January Currency
translation
30 September
amortization 2024 Additions Disposals Transfers differences 2024
Rights (194,372,892) (10,290,612) - - 4,766,939 (199,896,565)
Development expenses (245,091,492) (15,579,106) - - - (260,670,598)
Other intangible assets (8,561,807)) - - - - (8,561,807)
(448,026,191) (25,869,718) - - 4,766,939 (469,128,970)
Net Book Value 421,273,275 387,157,619

BESLER GIDA VE KİMYA SANAYİ VE TİCARET A.Ş. AND ITS SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 SEPTEMBER 2025

(Amounts expressed in the purchasing power of the Turkish Lira ("TRY") as of 30 September 2025, unless otherwise indicated.)

NOTE 11 - INTANGIBLE ASSETS (Continued)

Allocation of depreciation and amortization expenses of property, plant and equipments, intangible assets, and right-of-use assets as of 1 January - 30 September 2025 and 1 January - 30 September 2024 are as follows:

1 January - 1 January -
30 September 30 September
2025 2024
Cost of sales (401,688,034) (381,784,568)
Marketing, sales and distribution expense (Note 18) (80,516,487) (78,252,918)
General administration expenses (Note 18) (37,927,316) (21,088,179)
Research and development expenses (Note 18) (30,557,281) (33,198,893)
(550,689,118) (514,324,558)

NOTE 12 - GOVERNMENT GRANTS AND INCENTIVES

Investment Incentive Certificate numbered 535745 was received from the General Directorate of Incentives, Implementation and Foreign Capital of the Ministry of Industry and Technology of the Republic of Türkiye on July 21, 2022, The validity period of the Incentive Certificate is 4 years and expires on July 13, 2025, The support elements foreseen in the Investment Incentive Certificate are 100% customs exemption and Value Added Tax exemption, 2-year insurance premium employer share support and 50% Tax Deduction, The total amount of investment foreseen in the Investment Incentive Certificate is TRY 99,936,725, As of September 30, 2025, the investment amount realized within the scope of the incentive certificate is TRY 26,384,064.

Investment Incentive Certificate numbered 552413 was received from the General Directorate of Incentives, Implementation and Foreign Capital of the Ministry of Industry and Technology of the Republic of Türkiye on July 26, 2023, The validity period of the said Incentive Certificate is 3 years and expires on July 25, 2026, The validity period of the mentioned Incentive Certificate is 3 years and ends on 25 July 2026, The support elements foreseen in the Investment Incentive Certificate are 100% customs exemption and Value Added Tax exemption, 7 years of insurance premium employer's share support, 80% Tax Reduction and 40% Investment Contribution Rate support, Total amount of the investment foreseen in the Investment Incentive Certificate is TRY86,414,080, As of 30 September 2025, the amount of investment realized within the scope of the incentive certificate is TRY51,212,62.

The Group's rights that can be used by all companies that meet the criteria required by the legislation, regardless of sector; Incentives within the scope of research and development law (100% corporate tax, VAT exemption, etc,), inward processing permits, social security institution incentives and employer's insurance premium support.

BESLER GIDA VE KİMYA SANAYİ VE TİCARET A.Ş. AND ITS SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 SEPTEMBER 2025

(Amounts expressed in the purchasing power of the Turkish Lira ("TRY") as of 30 September 2025, unless otherwise indicated.)

NOTE 13 - PROVISIONS, CONTINGENT ASSETS AND LIABILITIES

Contingent Assets and Liabilities

Contingent assets and liabilities as of 30 September 2025, and 31 December 2024 are as follows:

30 September 31 December
Contingent assets 2025 2024
Letters of guarantees received 1,645,486,287 1,711,399,453
Bonds of guarantee received 43,642,922 8,937,297
Pledges and mortgages received 198,670 249,191
1,689,327,879 1,720,585,941

Letter of guarantees received, and mortgages received are comprised of the guarantees received from customers within the scope of credit risk.

30 September 31 December
Contingent liabilities 2025 2024
Mortgages given (*) 10,195,729,984 11,119,536,870
Guarantorship given (*) 5,642,906,626 6,415,271,595
Letters of guarantee given 1,714,857,467 1,513,418,041
17,553,494,077 19,048,226,506

(*) An amount of TRY 11,619,036,898 of the guarantees and mortgages provided has been given as collateral for Yıldız Holding's syndication loan.

The letters of guarantee issued consist of various letters provided to suppliers and public authorities in relation to the Group's operations.

30 September 31 December
Other short-term provisions 2025 2024
Provisions for cost expenses 27,023,831 3,724,033
Provisions for lawsuits 3,708,255 4,529,531
30,732,086 8,253,564

The movements of provisions for lawsuits as of 1 January - 30 September 2025 and 1 January - 30 September 2024 are as follows:

1 January - 1 January -
Movement of provision for lawsuits 30 September 2025 30 September 2024
Opening 4,529,531 6,004,154
Charge / (reversals) for the period 172,870 456,495
Monetary gain / (loss) (994,146) (1,584,797)
End of the period 3,708,255 4,875,852

BESLER GIDA VE KİMYA SANAYİ VE TİCARET A.Ş. AND ITS SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 SEPTEMBER 2025 (Amounts expressed in the purchasing power of the Turkish Lira ("TRY") as of 30 September 2025, unless otherwise indicated.)

NOTE 14 - COMMITMENTS AND CONTINGENCIES

Guarantee, pledge and mortgages given by the Group

Guarantee, pledge and mortgages ("GPM") in respect of commitment and contingencies realized in the ordinary course of business given for the periods ended 30 September 2025 and 31 December 2024 are as follows:

30 September
2025
31 December 2024
Original Currency Amount TRY Equivalent Original Currency Amount TRY equivalent
A,
CPMs given for Company's own legal personality
TRY 12,416,168,082 12,416,168,082 TL 15,359,921,327 15,359,921,327
(*) EUR 105,602,215 5,137,325,995 EUR 83,347,885 3,688,305,179
B,
CPMs given on behalf of fully consolidated
companies - - - -
C,
CPMs given in the normal course of business
activities on behalf of third parties - - - -
D,
Total amount of other CPMs
- - - -
i) Total amount of CPMs given on behalf of the parent - - - -
ii) Total amount of CPMs given to on behalf of other
Group
companies which are not in scope of B and C - - - -
iii) Total amount of CPMs given on behalf of third
parties which are not in scope of C - - - -
17,553,494,077 19,048,226,506

As of 30 September 2025, the Group has export commitments of EUR 20,000,000 and 375,000,000 TRY (31 December 2024: EUR39,335,975) The fulfillment period of export commitments is two years.

  • (*) On February 2018, Yıldız Holding A,Ş, started negotiations with the creditors in order to refinance the loan payables for which no guarantee was provided and the balances which are used by the itself and by various Yıldız Holding group entities in connection with the miscellaneous loan agreements the Holding company entered into with Turkish banks, The purpose of these negotiations is to move all loan payable balances to the level of Yıldız Holding A,Ş, within the framework of a single maturity, interest rate and payment plan.
  • The bank loans of the Company and its subsidiaries which in total TRY7,530 million in cash (Nominal: TRY745 Million) and TRY2,042 million non-cash (Nominal: TRY202 million) contingencies were moved to the level of Yıldız Holding A,Ş, through syndication, The Company's total debt has not increased as a result of the syndicated loan, but cash and non-cash loans are moved to Yıldız Holding A,Ş, level.

BESLER GIDA VE KİMYA SANAYİ VE TİCARET A.Ş. AND ITS SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 SEPTEMBER 2025

(Amounts expressed in the purchasing power of the Turkish Lira ("TRY") as of 30 September 2025, unless otherwise indicated.)

NOTE 15 - OTHER ASSETS AND LIABILITIES

30 September 31 December
Other current assets 2025 2024
Deferred VAT 398,944,391 291,145,140
Other 8,171,989 15,739,504
407,116,380 306,884,644
30 September 31 December
Other current liabilities 2025 2024
Taxes and funds payables 108,540,692 58,966,926
Other current liabilities 19,382,287 63,969,214
127,922,979 122,936,140

NOTE 16 - CAPITAL, RESERVES AND OTHER EQUITY ITEMS

As of 30 September 2025, the Company's capital was issued and consisted of 66,200,000,000 shares, each with a nominal value of TRY0,01 (31 December 2024: 66,200,000,000 shares).

The Group's shareholders and their share in the capital as of 30 September 2025 and 31 December 2024 are as follows:

30 September 2025 31 December 2024
Shareholders Share (%) Amount Share (%) Amount
Yıldız Holding A,Ş, 60,53 400,675,745 60,53 400,675,745
Murat Ülker 9,98 66,079,898 9,98 66,079,898
Other 29,49 195,244,357 29,49 195,244,357
Total 100 662,000,000 100 662,000,000

Restricted Reserves and Retained Earnings

The legal reserves consist of first and second legal reserves, appropriated in accordance with the Turkish Commercial Code, The first legal reserves are appropriated out of historical statutory profits at the rate of 5% per annum, until the total reserve reaches 20% of the historical paid-in share capital, The second legal reserves are appropriated after the first legal reserves and dividends, at the rate of 10% per annum of all cash dividend distributions, These reserves can only be used to cover losses, to maintain the company in times when things are not going well, or to prevent unemployment and to mitigate the effects of such losses, unless they exceed half of the paid-in capital of the company.

Restricted reserves allocated from profit as of September 30, 2025, are as follows, There is no remaining profit for the period after deducting previous years' losses in the legal records of the Group and there are no other resources that can be subject to profit distribution.

30 September 31 December
Restricted reserves 2025 2024
Legal reserves 724,553,593 724,553,593
724,553,593 724,553,593

These are reserves set aside from the profits of previous periods due to obligations arising from the law or contract or for certain purposes other than profit distribution, These reserves are shown based on their amounts in legal records, and the differences arising from the evaluations made within the framework of TFRS are associated with previous years' profits and losses.

BESLER GIDA VE KİMYA SANAYİ VE TİCARET A.Ş. AND ITS SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 SEPTEMBER 2025

(Amounts expressed in the purchasing power of the Turkish Lira ("TRY") as of 30 September 2025, unless otherwise indicated.)

NOTE 16 - CAPITAL, RESERVES AND OTHER EQUITY ITEMS (Continued)

(In
Nominal
Inflation
value adjustment effect Indexed Value
662,000,000 5,938,797,299 6,600,797,299
37,378,879 687,174,714 724,553,593
30 September 2025 (In Nominal Inflation
accordance with Tax Law) value adjustment effect Indexed Value
Paid capital 662,000,000 6,701,186,125 7,363,186,125
Legal reserves 44,837,076 908,859,513 953,696,589

NOTE 17 - REVENUE AND COST OF SALES

1 January -
30 September
2025
1 January -
30 September
2024
1 July -
30 September
2025
1 July -
30 September
2024
Domestic sales 27,699,831,692 27,437,549,774 9,682,426,326 9,155,561,267
Export sales 2,017,301,110 2,139,746,662 632,680,215 628,075,203
Other income 66,547,936 80,974,676 17,682,904 13,974,261
Gross sales 29,783,680,738 29,658,271,112 10,332,789,445 9,797,610,731
Sales returns and discounts (-) (7,384,933,235) (6,566,808,026) (2,760,408,831) (2,473,349,682)
Net sales 22,398,747,503 23,091,463,086 7,572,380,614 7,324,261,049
Cost of sales (-) (17,176,947,339) (18,227,199,339) (5,966,441,430) (5,830,336,945)
Gross profit 5,221,800,164 4,864,263,747 1,605,939,184 1,493,924,104

NOTE 18 - GENERAL ADMINISTRATIVE EXPENSES, MARKETING EXPENSES, RESEARCH AND DEVELOPMENT EXPENSES

1 January - 1 January - 1 July - 1 July -
Marketing, sales and distribution expenses 30 September 30 September 30 September 30 September
2025 2024 2025 2024
Personnel expenses (620,985,779) (524,604,408) (187,337,332) (163,199,667)
Transportation expenses (593,590,924) (697,352,784) (210,769,561) (236,705,405)
Advertisement expenses (452,389,544) (443,674,945) (113,443,781) (58,549,706)
Tax duties
and fees (*) (236,066,087) (212,741,714) (68,961,651) (60,546,702)
Brand usage expense (101,888,910) (146,134,565) (32,665,340) (46,172,898)
Rent expenses (89,062,886) (63,717,843) (25,931,275) (4,540,626)
Depreciation and amortization expense (Note
11)
(80,516,487) (78,252,918) (23,975,560) (32,062,583)
Energy expenses (47,960,226) (50,858,730) (21,016,523) (21,690,419)
Export expenses (37,988,553) (27,163,833) (10,756,812) (8,903,714)
Maintenance and repair expenses (17,683,278) (18,133,752) (5,069,802) (7,689,599)
Other (108,351,018) (145,882,054) (47,740,143) (62,381,811)
(2,386,483,692) (2,408,517,546) (747,667,780) (702,443,130)

(*) These are expenses incurred regarding the recycling contribution fee (RCF).

BESLER GIDA VE KİMYA SANAYİ VE TİCARET A.Ş. AND ITS SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 SEPTEMBER 2025

(Amounts expressed in the purchasing power of the Turkish Lira ("TRY") as of 30 September 2025, unless otherwise indicated.)

NOTE 18 - GENERAL ADMINISTRATIVE EXPENSES, MARKETING EXPENSES, RESEARCH AND DEVELOPMENT EXPENSES (Continued)

1 January - 1 January - 1 July - 1 July -
General administrative expenses 30 September
2025
30 September
2024
30 September
2025
30 September
2024
Externally provided benefits and services (406,705,124) (319,108,044) (123,050,058) (95,968,001)
Personnel expenses (235,463,785) (247,891,300) (77,446,391) (91,229,348)
Depreciation and amortization expense
(Note 11)
(37,927,316) (21,088,179) (22,626,798) (9,127,948)
Energy expenses (6,121,753) (8,212,091) (2,095,704) (3,824,251)
Rent expenses (5,918,667) (10,949,259) (2,304,050) (3,835,775)
Brand copyright expenses (4,458,929) (5,473,998) (1,480,025) (1,608,923)
Communication expenses (4,007,751) (3,075,310) (1,583,938) (1,217,087)
Other (60,722,408) (58,625,019) (20,787,259) (11,302,038)
(761,325,733) (674,423,200) (251,374,223) (218,113,371)
Research and development expenses 1 January -
30 September 2025
1 January -
30 September
2024
1 July -
30 September
2025
1 July -
30 September
2024
Depreciation and amortization expense
(Note 11)
(30,557,281) (33,198,893)) (9,676,653) (16,995,532)
Personnel expenses (17,772,583) (12,346,583) (3,721,750) (4,442,184)
Externally provided benefits and
services
(922,209) (142,278) (347,489) (40,593)
Analysis expenses (452,036) - (157,876) -
Other (1,328,937) (1,013,440) (440,739) (240,024)
(51,033,046) (46,701,194) (14,344,507) (21,718,333)

NOTE 19 - INCOME AND EXPENSES FROM INVESTMENT ACTIVITIES

1 January -
30 September
1 January -
30 September
1 July -
30 September
1 July -
30 September
Income from Investment Activities 2025 2024 2025 2024
Interest income 2,182,340,479 2,109,534,838 483,688,944 879,160,433
Exchange difference income 914,059,201 - 334,128,577 -
Rent income 60,016,872 50,320,345 18,896,737 17,622,572
Gain on sale of fixed assets 15,309,098 5,110,037 11,619,612 500,232
3,171,725,650 2,164,965,220 848,333,870 897,283,237
1 January -
30 September
1 January -
30 September
1 July -
30 September
1 July -
30 September
Expenses from Investment Activities 2025 2024 2025 2024
Exchange difference expenses - (41,533,542) - (6,397,051)
Other - (38,470) - (9,262)
- (41,572,012) - (6,406,313)

BESLER GIDA VE KİMYA SANAYİ VE TİCARET A.Ş. AND ITS SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 SEPTEMBER 2025

(Amounts expressed in the purchasing power of the Turkish Lira ("TRY") as of 30 September 2025, unless otherwise indicated.)

NOTE 20 - FINANCIAL INCOME AND EXPENSES

1 January - 1 January - 1 July - 1 July -
30 September 30 September 30 September 30 September
Financial income 2025 2024 2025 2024
Discount income from financing (*) - 129,332,855 - 12,026,018
- 129,332,855 - 12,026,018
1 January - 1 January - 1 July - 1 July -
30 September 30 September 30 September 30 September
Financial expense 2025 2024 2025 2024
Interest expense (1,330,486,365) (873,465,884) (575,091,806) (387,488,100)
Exchange difference expenses on loans (1,385,051,427) (738,165,095) (209,836,889) (335,451,055)
Commission expenses (186,540,579) (542,169,505) (68,287,829) (168,062,999)
Discount expenses from financing (*) (66,781,260) - (36,422,465) -
Other (40,376,183) (3,431,342) (10,926,516) (1,083,870)

(*) The positive/negative difference between the interest rate which is understood within the framework of the renovation agreement within the framework of the unionized loan in other long -term commercial debts of Group to Yıldız Holding A,Ş, and the interest rates valid in the market were accountable in accordance with TFRS 9.

(3,009,235,814) (2,157,231,826) (900,565,505) (892,086,024)

BESLER GIDA VE KİMYA SANAYİ VE TİCARET A.Ş. AND ITS SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 SEPTEMBER 2025

(Amounts expressed in the purchasing power of the Turkish Lira ("TRY") as of 30 September 2025, unless otherwise indicated.)

NOTE 21 – MONETARY GAIN LOSS

Non-monetary items 30 September 2025
Financial statement items (1,227,287,784)
Inventories 79,384,171
Prepaid expenses (short term) (2,777,902)
Property, plant and equipment 2,158,329,876
Intangible assets 66,691,529
Deferred tax liability (462,639,118)
Paid-in capital (1,338,245,285)
Other accumulated comprehensive income or expense
not to be reclassified to profit or loss (708,559,111)
Capital reserves (5,138,162)
Premiums related to shares (425,690,833)
Restricted reserves allocated from profits (161,002,417)
Effect of combinations involving entities or entities under common control (347,402,912)
Retained earnings / (losses) (80,237,620)
Profit or loss statement items 897,635,799
Revenue (1,931,500,031)
Cost of sales 2,201,226,947
Research and development expenses 20,520,018
Marketing, selling and distribution expenses 254,401,498
General administrative expenses 87,769,297
Income/expenses from investing activities (276,310,279)
Other income/expenses from operating activities 137,590,719
Financing income/expenses 253,634,337
Current tax expense 150,303,293
Net monetary position gains / (losses) (329,651,985)

BESLER GIDA VE KİMYA SANAYİ VE TİCARET A.Ş. AND ITS SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 SEPTEMBER 2025

(Amounts expressed in the purchasing power of the Turkish Lira ("TRY") as of 30 September 2025, unless otherwise indicated.)

NOTE 22 - INCOME TAXES (INCLUDING DEFERRED TAX ASSETS AND LIABILITIES)

The Group is subject to Turkish corporate taxes, Provision is made in the accompanying financial statements for the estimated charge based on the Group's results for the years and periods, Turkish tax legislation does not permit a parent company and its subsidiary to file a consolidated tax return, Therefore, current income taxes recognized in the accompanying consolidated financial statements, have been calculated on a separate-entity basis.

Corporate tax is applied on taxable corporate income, which is calculated from the statutory accounting profit by adding back non-deductible expenses, and by deducting dividends received from resident companies, other exempt income and investment incentives utilized.

In Türkiye, the corporate tax rate is 25% as of 30 September 2025 (31 December 2024: 25%), The corporate tax rate is applied to the net corporate income to be found as a result of adding the expenses that are not accepted as deductible in accordance with the tax laws to the commercial income of the corporations and deducting the exceptions and deductions in the tax laws.

The Corporate tax rate is applied to the corporate income of the corporations, which is the result of the addition of expenses that are not allowed to be deducted in accordance with the tax laws and the exemptions and discounts included in the tax laws, Losses can be carried forward for a maximum of 5 years, to be deducted from the taxable profits that will arise in future years, However, the losses incurred cannot be deducted retrospectively from the profits of previous years.

The 7061 numbered law on the Amendment of Some Tax Laws was entered into force by being published in the Official Gazette dated 5 December 2017 and numbered 30261, With the 89th article of this Law, amendments are made in the 5th article titled "Exceptions" of the Corporate Tax Law, The first paragraph of the article; With paragraph (a), the 75% exemption applied to the earnings arising from the sale of real estates which were stated in the assets of the institutions for two full years has been reduced to 50%, This amendment was entered into force on 5 December 2017.

30 September 31 December
Current income tax liabilities 2025 2024
Current income tax expense 448,908,242 856,811,492
Less: prepaid taxes (252,619,034) (220,716,169)
Current income tax liability / (asset) 196,289,208 636,095,323

Income tax expense for the periods ended 30 September 2025 and 31 December 2024 comprised of the following items:

1 January - 1 January -
30 September 2025 30 September 2024
Current income tax expense (392,120,897) (403,557,160)
Deferred tax income / (expense) (56,298,888) 452,249,866
Total tax income / (expense) (448,419,785) 48,692,706

Deferred Tax

The Group recognizes deferred tax assets and liabilities for temporary timing differences arising from the differences between the tax base legal financial statements and the financial statements prepared in accordance with TAS, These differences are generally due to the fact that some income and expense items are included in different periods in tax base financial statements and financial statements prepared in accordance with TAS, and these differences are stated below.

The tax rate used in the calculation of deferred tax assets and liabilities will be 25% for 2024, and 25% for 2025 taxation periods.

In Türkiye, the companies cannot declare a consolidated tax return, therefore subsidiaries that have deferred tax assets position were not netted off against subsidiaries that have deferred tax liabilities position and disclosed separately.

BESLER GIDA VE KİMYA SANAYİ VE TİCARET A.Ş. AND ITS SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 SEPTEMBER 2025

(Amounts expressed in the purchasing power of the Turkish Lira ("TRY") as of 30 September 2025, unless otherwise indicated.)

NOTE 22 - INCOME TAXES (INCLUDING DEFERRED TAX ASSETS AND LIABILITIES) (Continued)

As of 30 September 2025, and 31 December 2024 the breakdown of the accumulated temporary differences related to the Group and the deferred tax assets and liabilities using the applicable tax rates are as follows:

Deferred tax asset /
Total temporary differences (liability)
30 September
31 December
30 September 31 December
2025 2024 2025 2024
Provisions for employee
termination benefits 377,852,788 464,618,598 94,463,198 116,154,651
Provisions for doubtful receivables 48,880,680 28,992,131 12,220,170 7,248,033
Provisions for lawsuits 3,708,255 4,529,531 927,064 1,132,383
Provision for unused vacations 76,128,658 87,260,965 19,032,165 21,815,242
Carry-forward tax losses (*) 319,045,011 711,071,370 57,428,102 127,992,847
Discount income from financing (201,619,806) (329,494,467) (50,404,952) (82,373,617)
Exchange rate difference 228,293,701 275,163,895 57,073,425 68,790,974
activation
Net differences between the
carrying values and tax bases of
investment properties (3,274,992,281) (3,269,477,768) (818,748,070) (817,369,442)
Revaluation differences on
property, plant and equipment (5,032,011,182) (5,161,576,723) (1,009,474,189) (976,282,698)
Other (13,140,937) (479,746,079) (3,285,233) (119,936,520)
Deferred tax assets / (liabilities),
net (7,467,855,113) (7,668,658,547) (1,640,768,320) (1,652,828,147)

(*) As of 30 September 2025, based on the projections and future estimations, there is no previous year loss for which deferred tax is not recognized (31 December 2024: None).

NOTE 23 - EARNING PER SHARE

1 January - 30
September
2025
1 January - 30
September
2024
1 July - 30
September
2025
1 July - 30
September
2024
Net gain for the year attributable to equity (5,269,265) 1,308,018,676 148,917,209 542,118,578
holders of the parent
Weighted average number of shares 662,000,000 662,000,000 662,000,000 662,000,000
Earning per share (TRY) (0,0080) 1,9758 0,2250 0,8189

BESLER GIDA VE KİMYA SANAYİ VE TİCARET A.Ş. AND ITS SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 SEPTEMBER 2025

(Amounts expressed in the purchasing power of the Turkish Lira ("TRY") as of 30 September 2025, unless otherwise indicated.)

NOTE 24 - BORROWINGS

30 September 31 December
Short term borrowings 2025 2024
Short term foreign currency loans 5,318,194,760 3,676,436,438
Short term local currency loans 762,390,619 1,147,653,917
Short term lease labilities 40,609,982 101,439,393
6,121,195,361 4,925,529,748
30 September 31 December
Short Term Portion of Long-Term Borrowings 2025 2024
Bank loans 631,217,437 138,483,296
631,217,437 138,483,296
30 September 31 December
Long term borrowings 2025 2024
Long term foreign currency loans 1,595,337,157 1,059,420,611
Long term lease labilities 168,156,899 200,882,702
1,763,494,056 1,260,303,313

As of 30 September 2025, and 31 December 2024 details of short and long-term bank loans are as follows:

30 September 2025

Original Currency Maturity (%) Original Amount TRY Equivalent
USD April 2026 6,50-7,50 8,498,635 353,386,841
November 2025 – August 147,248,287 7,191,362,513
EUR 2027 5,25 – 10,40
TRY October, 2025 – Dec, 2025 37,00 – 58,00 762,390,619 762,390,619
8,307,139,973

31 December 2024

Original Currency Maturity (%) Original Amount TRY Equivalent
USD Jan, 2025 4,90 – 6,00 359,204 15,924,081
EUR Jan, 2025 - Dec, 2026 4,29 – 11,00 105,204,055 4,853,670,761
TRY Jan, 2025 - Sept, 2025 26,93 – 57,72 1,152,399,420 1,152,399,420
6,021,994,262

Details of short and long-term lease liabilities are as follows:

30 September 2025
-- ------------------- --
Original Currency Maturity (%) Original Amount TRY Equivalent
USD - - - -
EUR August 2025 – May 2028 9,50 – 14,04 2,373,665 115,719,017
TRY October 2025 – Feb 2028 35,00 – 49,00 93,047,864 93,047,864
208,766,881

31 December 2024

Original Currency Maturity (%) Original Amount TRY Equivalent
USD Jan, 2025 - Sept, 2025 5,25 1,934,894 85,776,914
EUR Jan, 2025 - Dec, 2027 11,96 – 14,04 2,319,054 107,050,081
TRY Jan, 2025 - Sept, 2028 16,83 – 49,00 109,495,100 109,495,100
302,322,095

BESLER GIDA VE KİMYA SANAYİ VE TİCARET A.Ş. AND ITS SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 SEPTEMBER 2025

(Amounts expressed in the purchasing power of the Turkish Lira ("TRY") as of 30 September 2025, unless otherwise indicated.)

NOTE 25 - NATURE AND LEVEL OF RISKS DERIVED FROM FINANCIAL INSTRUMENTS

Currency Risk Management

The Group is exposed to currency risk on its operations that are denominated in other currencies.

The distribution of the Group's foreign currency denominated monetary and non-monetary assets and monetary and non-monetary liabilities as of the balance sheet date is as follows:

30 September 2025 TRY Equivalent USD EUR Other
1, Trade Receivables 1,264,621,001 25,760,236 4,001,861 5,397
2a, Monetary Financial Assets 7,895,307,248 28,243,752 137,899,540 4,206
2b, Non-monetary Financial Assets - - - -
3, Other 879,894,651 264,030 17,823,652 201
4, CURRENT ASSETS (1+2+3) 10,039,822,900 54,268,018 159,725,053 9,804
5, Trade Receivables - - - -
6a, Monetary Financial Assets 855,988 20,623 - -
6b, Non-monetary Financial Assets - - - -
7, Other 22,125,026 31,973 426,614 -
8, NON-CURRENT ASSETS (5+6+7) 22,981,014 52,596 426,614 -
9, TOTAL ASSETS (4+8) 10,062,803,914 54,320,614 160,151,667 9,804
10, Trade Payables 4,163,011,128 11,688,659 75,208,070 69,507
11, Financial Liabilities 5,949,412,198 8,498,635 114,828,099 -
12a, Monetary Other Liabilities 59,404,295 1,010,868 355,674 -
12b, Non-Monetary Other Liabilities - - - -
13, CURRENT LIABILITIES (10+11+12) 10,171,827,621 21,198,162 190,391,843 69,507
14, Trade Payables - - - -
15, Financial Liabilities 1,711,056,173 - 34,793,853 -
16a, Monetary Other Liabilities 49,187,996 1,182,927 - -
16b, Non-Monetary Other Liabilities - - - -
17, NON-CURRENT LIABILITIES (14+15+16) 1,760,244,169 1,182,927 34,793,853 -
18, TOTAL LIABILITIES (13+17) 11,932,071,791 22,381,089 225,185,696 69,507
19 Off-balance Sheet Derivative Instruments
Net Asset/Liability Position (19a - 19b) - - - -
19a, Amount of active foreign derivative currency
off-balance sheet - - - -
19b, Amount of passive foreign derivative currency
off-balance sheet - - - -
20,Net Foreign Currency Assets/(Liabilities) (1,869,267,877) 31,939,525 (65,034,029) (59,703)
Position (9-18+19)
21,Monetary Items Net Foreign Currency Assets / (1,869,267,877) 31,939,525 (65,034,029) (59,703)
(Liabilities)(1+2a+3+5+6a-10-11-12a-14-15-16a)
22, Fair value of financial instruments used for - - - -
currency hedge
23, Hedged foreign currency assets - - - -

BESLER GIDA VE KİMYA SANAYİ VE TİCARET A.Ş. AND ITS SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 SEPTEMBER 2025

(Amounts expressed in the purchasing power of the Turkish Lira ("TRY") as of 30 September 2025, unless otherwise indicated.)

NOTE 25 - NATURE AND LEVEL OF RISKS DERIVED FROM FINANCIAL INSTRUMENTS (Continued)

31 December 2024 TRY Equivalent USD EUR Other
1, Trade Receivables 1,076,964,606 23,974,908 339,235 7,164
2a, Monetary Financial Assets 708,446,140 8,610,877 6,955,897 124,149
2b, Non-monetary Financial Assets - - - -
3, Other 245,126,829 745,649 4,603,718 -
4, CURRENT ASSETS (1+2+3) 2,030,537,575 33,331,434 11,898,850 131,313
5, Trade Receivables - - - -
6a, Monetary Financial Assets 836,383 18,900 - -
6b, Non-monetary Financial Assets - - - -
7, Other - - - -
8, NON-CURRENT ASSETS (5+6+7) 836,383 18,900 - -
9, TOTAL ASSETS (4+8) 2,031,373,958 33,350,334 11,898,850 131,313
10, Trade Payables 3,686,718,966 6,964,477 73,213,457 82,402
11, Financial Liabilities 3,841,714,811 359,204 82,936,820 -
12a, Monetary Other Liabilities 126,050,992 1,312,292 1,474,408 -
12b, Non-Monetary Other Liabilities - - - -
13, CURRENT LIABILITIES (10+11+12) 7,654,484,769 8,635,973 157,624,685 82,402
14, Trade Payables 5,556,681 125,344 - -
15, Financial Liabilities 1,220,707,025 1,934,894 24,586,289 -
16a, Monetary Other Liabilities 53,246,117 1,203,249 - -
16b, Non-Monetary Other Liabilities - - - -
17, NON-CURRENT LIABILITIES (14+15+16) 1,279,509,823 3,263,487 24,586,289 -
18, TOTAL LIABILITIES (13+17) 8,933,994,592 11,899,460 182,210,974 82,402
19 Off-balance Sheet Derivative Instruments
Net Asset/Liability Position (19a - 19b) - - - -
19a, Amount of active foreign derivative currency
off-balance sheet - - - -
19b, Amount of passive foreign derivative currency
off-balance sheet - - - -
20, Net Foreign Currency Assets/(Liabilities) (6,902,620,634) 21,450,874 (170,312,124) 48,911
Position (9-18+19)
21, Monetary Items Net Foreign Currency Assets / (6,902,620,634) 21,450,874 (170,312,124) 48,911
(Liabilities)(1+2a+3+5+6a-10-11-12a-14-15-16a)
22, Fair value of financial instruments used for
currency hedge - - - -
23, Hedged foreign currency assets - - - -

The export and import amounts realized by the Group as of 30 September 2025 and 2024 are as follows:

1 January- 30
September
2025
1 January- 30
September
2024
Total exports 2,017,301,110 2,139,746,662
Total imports (3,726,012,239) (5,057,599,782)

BESLER GIDA VE KİMYA SANAYİ VE TİCARET A.Ş. AND ITS SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 SEPTEMBER 2025

(Amounts expressed in the purchasing power of the Turkish Lira ("TRY") as of 30 September 2025, unless otherwise indicated.)

NOTE 25 - NATURE AND LEVEL OF RISKS DERIVED FROM FINANCIAL INSTRUMENTS (Continued)

Sensitivity Analysis to Currency Risk

The Group is mainly exposed to foreign currency risks in USD and EUR, The following table shows the Group's sensitivity to a 10% increase and decrease in USD and EUR, 10% is the sensitivity rate used when reporting foreign currency risk internally to key management personnel and represents management's assessment of the possible change in foreign exchange rates, The sensitivity analysis only includes outstanding foreign currency denominated monetary items and adjusts their translation at the period end for a 10% change in foreign currency rates, This analysis comprises the borrowings used for foreign operations within the Group outside the functional currency, A positive number indicates an increase in profit / loss and other equity.

Profit/Loss
Appreciation foreign Depreciation foreign
30 September 2025 currency currency
In case of USD increases in 10% against TRY
1- USD net asset/liability 132,525,118 (132,525,118)
2- USD hedged portion (-) - -
3- Net effect of USD (1 +2) 132,525,118 (132,525,118)
In case of EUR increases in 10% against TRY
4- EUR net asset/liability (318,703,062) 318,703,062
5- EUR hedged portion (-) - -
6- Net effect of EUR (4+5) (318,703,062) 318,703,062
In case of other currencies increases in 10% against TRY
7- EUR net asset/liability (748,844) 748,844
8- EUR hedged portion (-) - -
9- Net effect of other currencies (4+5) (748,844) 748,844
TOTAL (3+6+9) (186,926,788) 186,926,788
Profit/Loss
31 December 2024 Appreciation foreign
currency
Depreciation foreign
currency
In case of USD increases in 10% against TRY
1- USD net asset/liability 89,168,152 (89,168,152)
2- USD hedged portion (-) - -
3- Net effect of USD (1 +2) 89,168,152 (89,168,152)
In case of EUR increases in 10% against TRY
4- EUR net asset/liability (831,910,536) 831,910,536
5- EUR hedged portion (-) - -
6- Net effect of EUR (4+5) (831,910,536) 831,910,536
In case of other currencies increases in 10% against TRY
7- EUR net asset/liability 52,480,320 (52,480,320)
8- EUR hedged portion (-) - -
9- Net effect of other currencies (4+5) 52,480,320 (52,480,320)
TOTAL (3+6+9) (690,262,064) 690,262,064

BESLER GIDA VE KİMYA SANAYİ VE TİCARET A.Ş. AND ITS SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 SEPTEMBER 2025

(Amounts expressed in the purchasing power of the Turkish Lira ("TRY") as of 30 September 2025, unless otherwise indicated.)

NOTE 25 - NATURE AND LEVEL OF RISKS DERIVED FROM FINANCIAL INSTRUMENTS (Continued)

Interest Rate Risk Management

The Group's borrowings with fixed and variable interest rates exposes the Group to interest rate risk.

The interest rate profile of the Group's interest-bearing financial instruments are as follows:

30 September 31 December
Interest Position 2025 2024
Fixed interest rate instruments
Borrowings 8,515,906,854 6,324,316,357
Cash and cash equivalents (term deposits) 1,947,299,793 2,315,431,808
Trade receivables 4,696,858,263 4,443,385,260
Trade payables 6,090,984,233 6,284,497,145
Other payables 562,035,394 638,245,639
Variable interest rate instruments
Other receivables 9,161,940,151 7,642,028,192
Other payables 2,354,088,277 1,874,854,423

NOTE 26 - CASH AND CASH EQUIVALENTS

NOTE 27 - SUBSEQUENT EVENTS

30 September 31 December
2025 2024
Cash at banks 2,783,056,477 2,518,225,018
- Demand deposits 835,756,684 202,793,210
- Time deposits (*) 1,947,299,793 2,315,431,808
Credit card receivables 75,661,349 127,078,512
2,858,717,826 2,645,303,530

(*) The maturity of the balances constituting the relevant amount is October 1, 2025, and the interest rate for Turkish Lira-based time deposits is 40,00%-40,50% and for US Dollar-based time deposits it is 1,50%, (December 31, 2024: The interest rate for TRY-based time deposits is 48,92%, and for EUR-based time deposits it is 1,25%)

None. ……………………………………………………

Talk to a Data Expert

Have a question? We'll get back to you promptly.